In women with generally recognised risk factors for thrombo-embolic events, such as personal or family history, treatment with gonadotrophins may further increase the risk.
For kvinder med kendt risiko for tromboemboliske tilstand, personlig eller familiehistorisk, kan behandling med gonadotropin øge risikoen.